Global Parenteral Drugs Market Research Report 2021

Global Parenteral Drugs Market Research Report 2021

Table of Contents
1 Parenteral Drugs Market Overview
1.1 Product Overview and Scope of Parenteral Drugs
1.2 Parenteral Drugs Segment
1.2.1 Global Parenteral Drugs Sales Growth Rate Comparison (2021-2027)
1.2.2 LVP Drug
1.2.3 SVP Drug
1.3 Parenteral Drugs Segment
1.3.1 Parenteral Drugs Sales Comparison : (2021-2027)
1.3.2 Hospitals
1.3.3 Medical Centers
1.3.4 Others
1.4 Global Parenteral Drugs Market Size Estimates and Forecasts
1.4.1 Global Parenteral Drugs Revenue 2016-2027
1.4.2 Global Parenteral Drugs Sales 2016-2027
1.4.3 Parenteral Drugs Market Size by Region: 2016 Versus 2021 Versus 2027
2 Parenteral Drugs Market Competition by Manufacturers
2.1 Global Parenteral Drugs Sales Market Share by Manufacturers (2016-2021)
2.2 Global Parenteral Drugs Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Parenteral Drugs Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Parenteral Drugs Manufacturing Sites, Area Served, Product Type
2.5 Parenteral Drugs Market Competitive Situation and Trends
2.5.1 Parenteral Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Parenteral Drugs Players Market Share by Revenue
2.5.3 Global Parenteral Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Parenteral Drugs Retrospective Market Scenario by Region
3.1 Global Parenteral Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Parenteral Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Parenteral Drugs Market Facts & Figures by Country
3.3.1 North America Parenteral Drugs Sales by Country
3.3.2 North America Parenteral Drugs Revenue by Country
3.3.3 United States
3.3.4 Canada
3.3.3 Mexico
3.4 Europe Parenteral Drugs Market Facts & Figures by Country
3.4.1 Europe Parenteral Drugs Sales by Country
3.4.2 Europe Parenteral Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Parenteral Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Parenteral Drugs Sales by Region
3.5.2 Asia Pacific Parenteral Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Parenteral Drugs Market Facts & Figures by Country
3.6.1 Latin America Parenteral Drugs Sales by Country
3.6.2 Latin America Parenteral Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Parenteral Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Parenteral Drugs Sales by Country
3.7.2 Middle East and Africa Parenteral Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Parenteral Drugs Historic Market Analysis
4.1 Global Parenteral Drugs Sales Market Share (2016-2021)
4.2 Global Parenteral Drugs Revenue Market Share (2016-2021)
4.3 Global Parenteral Drugs Price (2016-2021)
5 Global Parenteral Drugs Historic Market Analysis
5.1 Global Parenteral Drugs Sales Market Share (2016-2021)
5.2 Global Parenteral Drugs Revenue Market Share (2016-2021)
5.3 Global Parenteral Drugs Price (2016-2021)
6 Key Companies Profiled
6.1 Ostuka Pharmaceutical
6.1.1 Ostuka Pharmaceutical Corporation Information
6.1.2 Ostuka Pharmaceutical Description and Business Overview
6.1.3 Ostuka Pharmaceutical Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Ostuka Pharmaceutical Product Portfolio
6.1.5 Ostuka Pharmaceutical Recent Developments/Updates
6.2 Teva Pharmaceutical Industries
6.2.1 Teva Pharmaceutical Industries Corporation Information
6.2.2 Teva Pharmaceutical Industries Description and Business Overview
6.2.3 Teva Pharmaceutical Industries Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Teva Pharmaceutical Industries Product Portfolio
6.2.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.3 Kelun Pharma
6.3.1 Kelun Pharma Corporation Information
6.3.2 Kelun Pharma Description and Business Overview
6.3.3 Kelun Pharma Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Kelun Pharma Product Portfolio
6.3.5 Kelun Pharma Recent Developments/Updates
6.4 Cook Pharmica
6.4.1 Cook Pharmica Corporation Information
6.4.2 Cook Pharmica Description and Business Overview
6.4.3 Cook Pharmica Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Cook Pharmica Product Portfolio
6.4.5 Cook Pharmica Recent Developments/Updates
6.5 Patheon
6.5.1 Patheon Corporation Information
6.5.2 Patheon Description and Business Overview
6.5.3 Patheon Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Patheon Product Portfolio
6.5.5 Patheon Recent Developments/Updates
6.6 BAG Healthcare
6.6.1 BAG Healthcare Corporation Information
6.6.2 BAG Healthcare Description and Business Overview
6.6.3 BAG Healthcare Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021)
6.6.4 BAG Healthcare Product Portfolio
6.6.5 BAG Healthcare Recent Developments/Updates
6.7 Beximco Pharma
6.6.1 Beximco Pharma Corporation Information
6.6.2 Beximco Pharma Description and Business Overview
6.6.3 Beximco Pharma Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Beximco Pharma Product Portfolio
6.7.5 Beximco Pharma Recent Developments/Updates
6.8 Baxter Healthcare Corporation
6.8.1 Baxter Healthcare Corporation Corporation Information
6.8.2 Baxter Healthcare Corporation Description and Business Overview
6.8.3 Baxter Healthcare Corporation Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Baxter Healthcare Corporation Product Portfolio
6.8.5 Baxter Healthcare Corporation Recent Developments/Updates
6.9 B. Braun
6.9.1 B. Braun Corporation Information
6.9.2 B. Braun Description and Business Overview
6.9.3 B. Braun Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021)
6.9.4 B. Braun Product Portfolio
6.9.5 B. Braun Recent Developments/Updates
6.10 Fresenius
6.10.1 Fresenius Corporation Information
6.10.2 Fresenius Description and Business Overview
6.10.3 Fresenius Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Fresenius Product Portfolio
6.10.5 Fresenius Recent Developments/Updates
6.11 Albert David
6.11.1 Albert David Corporation Information
6.11.2 Albert David Parenteral Drugs Description and Business Overview
6.11.3 Albert David Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Albert David Product Portfolio
6.11.5 Albert David Recent Developments/Updates
6.12 BML Parenteral Drugs
6.12.1 BML Parenteral Drugs Corporation Information
6.12.2 BML Parenteral Drugs Parenteral Drugs Description and Business Overview
6.12.3 BML Parenteral Drugs Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021)
6.12.4 BML Parenteral Drugs Product Portfolio
6.12.5 BML Parenteral Drugs Recent Developments/Updates
6.13 Pfizer (Hospira)
6.13.1 Pfizer (Hospira) Corporation Information
6.13.2 Pfizer (Hospira) Parenteral Drugs Description and Business Overview
6.13.3 Pfizer (Hospira) Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Pfizer (Hospira) Product Portfolio
6.13.5 Pfizer (Hospira) Recent Developments/Updates
6.14 Pisa
6.14.1 Pisa Corporation Information
6.14.2 Pisa Parenteral Drugs Description and Business Overview
6.14.3 Pisa Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Pisa Product Portfolio
6.14.5 Pisa Recent Developments/Updates
6.15 Ozon Pharmaceuticals Ltd
6.15.1 Ozon Pharmaceuticals Ltd Corporation Information
6.15.2 Ozon Pharmaceuticals Ltd Parenteral Drugs Description and Business Overview
6.15.3 Ozon Pharmaceuticals Ltd Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Ozon Pharmaceuticals Ltd Product Portfolio
6.15.5 Ozon Pharmaceuticals Ltd Recent Developments/Updates
6.16 Aspen Holdings
6.16.1 Aspen Holdings Corporation Information
6.16.2 Aspen Holdings Parenteral Drugs Description and Business Overview
6.16.3 Aspen Holdings Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Aspen Holdings Product Portfolio
6.16.5 Aspen Holdings Recent Developments/Updates
6.17 PSI Ltd
6.17.1 PSI Ltd Corporation Information
6.17.2 PSI Ltd Parenteral Drugs Description and Business Overview
6.17.3 PSI Ltd Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021)
6.17.4 PSI Ltd Product Portfolio
6.17.5 PSI Ltd Recent Developments/Updates
6.18 Wintac Limited
6.18.1 Wintac Limited Corporation Information
6.18.2 Wintac Limited Parenteral Drugs Description and Business Overview
6.18.3 Wintac Limited Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021)
6.18.4 Wintac Limited Product Portfolio
6.18.5 Wintac Limited Recent Developments/Updates
6.19 AXA Parenterals Ltd
6.19.1 AXA Parenterals Ltd Corporation Information
6.19.2 AXA Parenterals Ltd Parenteral Drugs Description and Business Overview
6.19.3 AXA Parenterals Ltd Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021)
6.19.4 AXA Parenterals Ltd Product Portfolio
6.19.5 AXA Parenterals Ltd Recent Developments/Updates
6.20 Acebright
6.20.1 Acebright Corporation Information
6.20.2 Acebright Parenteral Drugs Description and Business Overview
6.20.3 Acebright Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021)
6.20.4 Acebright Product Portfolio
6.20.5 Acebright Recent Developments/Updates
6.21 Southwest Pharmaceutical
6.21.1 Southwest Pharmaceutical Corporation Information
6.21.2 Southwest Pharmaceutical Parenteral Drugs Description and Business Overview
6.21.3 Southwest Pharmaceutical Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021)
6.21.4 Southwest Pharmaceutical Product Portfolio
6.21.5 Southwest Pharmaceutical Recent Developments/Updates
6.22 Abbott
6.22.1 Abbott Corporation Information
6.22.2 Abbott Parenteral Drugs Description and Business Overview
6.22.3 Abbott Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021)
6.22.4 Abbott Product Portfolio
6.22.5 Abbott Recent Developments/Updates
7 Parenteral Drugs Manufacturing Cost Analysis
7.1 Parenteral Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Parenteral Drugs
7.4 Parenteral Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Parenteral Drugs Distributors List
8.3 Parenteral Drugs Customers
9 Parenteral Drugs Market Dynamics
9.1 Parenteral Drugs Industry Trends
9.2 Parenteral Drugs Growth Drivers
9.3 Parenteral Drugs Market Challenges
9.4 Parenteral Drugs Market Restraints
10 Global Market Forecast
10.1 Parenteral Drugs Market Estimates and Projections
10.1.1 Global Forecasted Sales of Parenteral Drugs (2022-2027)
10.1.2 Global Forecasted Revenue of Parenteral Drugs (2022-2027)
10.2 Parenteral Drugs Market Estimates and Projections
10.2.1 Global Forecasted Sales of Parenteral Drugs (2022-2027)
10.2.2 Global Forecasted Revenue of Parenteral Drugs (2022-2027)
10.3 Parenteral Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Parenteral Drugs by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Parenteral Drugs by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Parenteral Drugs Sales (K Units) Growth Rate Comparison (2021-2027)
Table 2. Global Parenteral Drugs Sales (K Units) Comparison (2021-2027)
Table 3. Global Parenteral Drugs Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Parenteral Drugs Covered in This Study
Table 5. Global Parenteral Drugs Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Parenteral Drugs Sales Share by Manufacturers (2016-2021)
Table 7. Global Parenteral Drugs Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Parenteral Drugs Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Parenteral Drugs Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Parenteral Drugs Manufacturing Sites and Area Served
Table 11. Manufacturers Parenteral Drugs Product Type
Table 12. Global Parenteral Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Parenteral Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parenteral Drugs as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Parenteral Drugs Sales by Region (2016-2021) & (K Units)
Table 16. Global Parenteral Drugs Sales Market Share by Region (2016-2021)
Table 17. Global Parenteral Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Parenteral Drugs Sales by Country (2016-2021) & (K Units)
Table 19. North America Parenteral Drugs Sales Market Share by Country (2016-2021)
Table 20. North America Parenteral Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Parenteral Drugs Revenue Market Share by Country (2016-2021)
Table 22. Europe Parenteral Drugs Sales by Country (2016-2021) & (K Units)
Table 23. Europe Parenteral Drugs Sales Market Share by Country (2016-2021)
Table 24. Europe Parenteral Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Parenteral Drugs Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Parenteral Drugs Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Parenteral Drugs Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Parenteral Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Parenteral Drugs Revenue Market Share by Region (2016-2021)
Table 30. Latin America Parenteral Drugs Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Parenteral Drugs Sales Market Share by Country (2016-2021)
Table 32. Latin America Parenteral Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Parenteral Drugs Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Parenteral Drugs Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Parenteral Drugs Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Parenteral Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Parenteral Drugs Revenue Market Share by Country (2016-2021)
Table 38. Global Parenteral Drugs Sales (K Units) (2016-2021)
Table 39. Global Parenteral Drugs Sales Market Share (2016-2021)
Table 40. Global Parenteral Drugs Revenue (Million US$) (2016-2021)
Table 41. Global Parenteral Drugs Revenue Share (2016-2021)
Table 42. Global Parenteral Drugs Price (USD/Unit) (2016-2021)
Table 43. Global Parenteral Drugs Sales (K Units) (2016-2021)
Table 44. Global Parenteral Drugs Sales Market Share (2016-2021)
Table 45. Global Parenteral Drugs Revenue (Million US$) (2016-2021)
Table 46. Global Parenteral Drugs Revenue Share (2016-2021)
Table 47. Global Parenteral Drugs Price (USD/Unit) (2016-2021)
Table 48. Ostuka Pharmaceutical Corporation Information
Table 49. Ostuka Pharmaceutical Description and Business Overview
Table 50. Ostuka Pharmaceutical Parenteral Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Ostuka Pharmaceutical Parenteral Drugs Product
Table 52. Ostuka Pharmaceutical Recent Developments/Updates
Table 53. Teva Pharmaceutical Industries Corporation Information
Table 54. Teva Pharmaceutical Industries Description and Business Overview
Table 55. Teva Pharmaceutical Industries Parenteral Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Teva Pharmaceutical Industries Parenteral Drugs Product
Table 57. Teva Pharmaceutical Industries Recent Developments/Updates
Table 58. Kelun Pharma Corporation Information
Table 59. Kelun Pharma Description and Business Overview
Table 60. Kelun Pharma Parenteral Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Kelun Pharma Parenteral Drugs Product
Table 62. Kelun Pharma Recent Developments/Updates
Table 63. Cook Pharmica Corporation Information
Table 64. Cook Pharmica Description and Business Overview
Table 65. Cook Pharmica Parenteral Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Cook Pharmica Parenteral Drugs Product
Table 67. Cook Pharmica Recent Developments/Updates
Table 68. Patheon Corporation Information
Table 69. Patheon Description and Business Overview
Table 70. Patheon Parenteral Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Patheon Parenteral Drugs Product
Table 72. Patheon Recent Developments/Updates
Table 73. BAG Healthcare Corporation Information
Table 74. BAG Healthcare Description and Business Overview
Table 75. BAG Healthcare Parenteral Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. BAG Healthcare Parenteral Drugs Product
Table 77. BAG Healthcare Recent Developments/Updates
Table 78. Beximco Pharma Corporation Information
Table 79. Beximco Pharma Description and Business Overview
Table 80. Beximco Pharma Parenteral Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. Beximco Pharma Parenteral Drugs Product
Table 82. Beximco Pharma Recent Developments/Updates
Table 83. Baxter Healthcare Corporation Corporation Information
Table 84. Baxter Healthcare Corporation Description and Business Overview
Table 85. Baxter Healthcare Corporation Parenteral Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 86. Baxter Healthcare Corporation Parenteral Drugs Product
Table 87. Baxter Healthcare Corporation Recent Developments/Updates
Table 88. B. Braun Corporation Information
Table 89. B. Braun Description and Business Overview
Table 90. B. Braun Parenteral Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. B. Braun Parenteral Drugs Product
Table 92. B. Braun Recent Developments/Updates
Table 93. Fresenius Corporation Information
Table 94. Fresenius Description and Business Overview
Table 95. Fresenius Parenteral Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. Fresenius Parenteral Drugs Product
Table 97. Fresenius Recent Developments/Updates
Table 98. Albert David Corporation Information
Table 99. Albert David Description and Business Overview
Table 100. Albert David Parenteral Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 101. Albert David Parenteral Drugs Product
Table 102. Albert David Recent Developments/Updates
Table 103. BML Parenteral Drugs Corporation Information
Table 104. BML Parenteral Drugs Description and Business Overview
Table 105. BML Parenteral Drugs Parenteral Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 106. BML Parenteral Drugs Parenteral Drugs Product
Table 107. BML Parenteral Drugs Recent Developments/Updates
Table 108. Pfizer (Hospira) Corporation Information
Table 109. Pfizer (Hospira) Description and Business Overview
Table 110. Pfizer (Hospira) Parenteral Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 111. Pfizer (Hospira) Parenteral Drugs Product
Table 112. Pfizer (Hospira) Recent Developments/Updates
Table 113. Pisa Corporation Information
Table 114. Pisa Description and Business Overview
Table 115. Pisa Parenteral Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 116. Pisa Parenteral Drugs Product
Table 117. Pisa Recent Developments/Updates
Table 118. Ozon Pharmaceuticals Ltd Corporation Information
Table 119. Ozon Pharmaceuticals Ltd Description and Business Overview
Table 120. Ozon Pharmaceuticals Ltd Parenteral Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 121. Ozon Pharmaceuticals Ltd Parenteral Drugs Product
Table 122. Ozon Pharmaceuticals Ltd Recent Developments/Updates
Table 123. Aspen Holdings Corporation Information
Table 124. Aspen Holdings Description and Business Overview
Table 125. Aspen Holdings Parenteral Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 126. Aspen Holdings Parenteral Drugs Product
Table 127. Aspen Holdings Recent Developments/Updates
Table 128. PSI Ltd Corporation Information
Table 129. PSI Ltd Description and Business Overview
Table 130. PSI Ltd Parenteral Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 131. PSI Ltd Parenteral Drugs Product
Table 132. PSI Ltd Recent Developments/Updates
Table 133. Wintac Limited Corporation Information
Table 134. Wintac Limited Description and Business Overview
Table 135. Wintac Limited Parenteral Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 136. Wintac Limited Parenteral Drugs Product
Table 137. Wintac Limited Recent Developments/Updates
Table 138. AXA Parenterals Ltd Corporation Information
Table 139. AXA Parenterals Ltd Description and Business Overview
Table 140. AXA Parenterals Ltd Parenteral Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 141. AXA Parenterals Ltd Parenteral Drugs Product
Table 142. AXA Parenterals Ltd Recent Developments/Updates
Table 143. Acebright Corporation Information
Table 144. Acebright Description and Business Overview
Table 145. Acebright Parenteral Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 146. Acebright Parenteral Drugs Product
Table 147. Acebright Recent Developments/Updates
Table 148. Southwest Pharmaceutical Corporation Information
Table 149. Southwest Pharmaceutical Description and Business Overview
Table 150. Southwest Pharmaceutical Parenteral Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 151. Southwest Pharmaceutical Parenteral Drugs Product
Table 152. Southwest Pharmaceutical Recent Developments/Updates
Table 153. Abbott Corporation Information
Table 154. Abbott Description and Business Overview
Table 155. Abbott Parenteral Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 156. Abbott Parenteral Drugs Product
Table 157. Abbott Recent Developments/Updates
Table 158. Production Base and Market Concentration Rate of Raw Material
Table 159. Key Suppliers of Raw Materials
Table 160. Parenteral Drugs Distributors List
Table 161. Parenteral Drugs Customers List
Table 162. Parenteral Drugs Market Trends
Table 163. Parenteral Drugs Growth Drivers
Table 164. Parenteral Drugs Market Restraints
Table 165. Global Parenteral Drugs Sales Forecast (2022-2027) & (K Units)
Table 166. Global Parenteral Drugs Sales Market Share Forecast (2022-2027)
Table 167. Global Parenteral Drugs Revenue Forecast (2022-2027) & (US$ Million)
Table 168. Global Parenteral Drugs Revenue Market Share Forecast (2022-2027)
Table 169. Global Parenteral Drugs Sales Forecast (2022-2027) & (K Units)
Table 170. Global Parenteral Drugs Sales Market Share Forecast (2022-2027)
Table 171. Global Parenteral Drugs Revenue Forecast (2022-2027) & (US$ Million)
Table 172. Global Parenteral Drugs Revenue Market Share Forecast (2022-2027)
Table 173. Global Parenteral Drugs Sales Forecast by Region (2022-2027) & (K Units)
Table 174. Global Parenteral Drugs Sales Market Share Forecast by Region (2022-2027)
Table 175. Global Parenteral Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 176. Global Parenteral Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 177. Research Programs/Design for This Report
Table 178. Key Data Information from Secondary Sources
Table 179. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Parenteral Drugs
Figure 2. Global Parenteral Drugs Market Share in 2020 & 2027
Figure 3. LVP Drug Product Picture
Figure 4. SVP Drug Product Picture
Figure 5. Global Parenteral Drugs Market Share in 2020 & 2027
Figure 6. Hospitals
Figure 7. Medical Centers
Figure 8. Others
Figure 9. Global Parenteral Drugs Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Parenteral Drugs Market Size 2016-2027 (US$ Million)
Figure 11. Global Parenteral Drugs Sales 2016-2027 (K Units)
Figure 12. Global Parenteral Drugs Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Parenteral Drugs Sales Share by Manufacturers in 2020
Figure 14. Global Parenteral Drugs Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Parenteral Drugs Players: Market Share by Revenue in 2020
Figure 16. Parenteral Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Parenteral Drugs Sales Market Share by Region (2016-2021)
Figure 18. Global Parenteral Drugs Sales Market Share by Region in 2020
Figure 19. Global Parenteral Drugs Revenue Market Share by Region (2016-2021)
Figure 20. Global Parenteral Drugs Revenue Market Share by Region in 2020
Figure 21. United States Parenteral Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Parenteral Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Mexico Parenteral Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Parenteral Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Parenteral Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. Parenteral Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Parenteral Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Parenteral Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Parenteral Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Parenteral Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Parenteral Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Parenteral Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Parenteral Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Taiwan Parenteral Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia Parenteral Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand Parenteral Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia Parenteral Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Philippines Parenteral Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Vietnam Parenteral Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Mexico Parenteral Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Brazil Parenteral Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Argentina Parenteral Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Turkey Parenteral Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Saudi Arabia Parenteral Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. U.A.E Parenteral Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Sales Market Share of Parenteral Drugs (2016-2021)
Figure 47. Sales Market Share of Parenteral Drugs (2016-2021)
Figure 48. Sales Market Share of Parenteral Drugs in 2020
Figure 49. Revenue Share of Parenteral Drugs (2016-2021)
Figure 50. Revenue Share of Parenteral Drugs in 2020
Figure 51. Manufacturing Cost Structure of Parenteral Drugs
Figure 52. Manufacturing Process Analysis of Parenteral Drugs
Figure 53. Parenteral Drugs Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs